Intra-Cellular Therapies Inc. (23I)
Market Closed
1 Apr, 20:00
XBER €
122. 00
+1
+0.83%
€
8.19B Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
€ 121
Previous Close Day Range
121 122
Year Range
59.5 126
Want to track 23I and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
23I closed Tuesday higher at €122, an increase of 0.83% from Monday's close, completing a monthly decrease of -0.81% or €1. Over the past 12 months, 23I stock gained 51.55%.
23I is not paying dividends to its shareholders.
The last earnings report, released on May 05, 2025, exceeded the consensus estimates by 0.32%. On average, the company has surpassed earnings expectations by 0.09%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XBER (EUR).
23I Chart
No Data
Intra-Cellular Therapies Inc. (23I) FAQ
What is the stock price today?
The current price is €122.00.
On which exchange is it traded?
Intra-Cellular Therapies Inc. is listed on XBER.
What is its stock symbol?
The ticker symbol is 23I.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 8.19B.
Has Intra-Cellular Therapies Inc. ever had a stock split?
No, there has never been a stock split.
2025 © Marketlog. All Rights Reserved.
